[Translation] A phase III clinical study of the efficacy of crenolanib combined with chemotherapy versus chemotherapy alone in relapsed/refractory FLT3 mutant AML
To evaluate the efficacy of crenolanib or placebo combined with salvage chemotherapy, consolidation therapy (cytarabine and/or allogeneic hematopoietic stem cell transplantation), and single-agent maintenance therapy in patients with relapsed/refractory FLT3-mutant acute myeloid leukemia
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.